Riken Vitamin Co., Ltd.

Riken Vitamin Co., Ltd.

TTSE:4526
3,235.00
JPY
+25.00
(+0.78%)
83.83BMarket Cap
Nov 12Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
1,931.51
1,935.67
1,998.82
2,718.46
2,740.31
2,715.64
2,530.7
2,370.08
2,415.58
2,705.23
2,805.02
3,157.02
3,260.32
- -
Basic EPS, GAAP
81.18
85.81
93.71
135.02
172.66
94.11
-272.46
-49.34
657.99
195.51
268.44
310.08
238.18
- -
Free Cash Flow per Basic Share
30.12
7.33
53.95
163.33
83.08
82.82
14.15
117.56
104.88
172.77
227.63
98.72
26.81
- -
Dividend per Share
18.99
28.72
31.75
39.82
32.63
38.16
41.97
43
42.23
48.22
67.27
91.69
109.76
- -
Book Value per Share
1,507.45
1,706.66
1,678.6
1,680.1
1,811.9
1,839.48
1,411.85
1,407.44
2,027.8
2,174.35
2,523.84
2,649.94
2,855.27
- -
Tangible Book Value per Share
1,484.07
1,680.79
1,658.11
1,655.74
1,790.6
1,819.47
1,391.51
1,386.67
2,006.52
2,154.69
2,491.68
2,617.14
2,820.63
- -
Basic Weighted Avg Shares
44
44
44
32
33
33
33
33
33
33
33
30
30
29
Sales/Revenue/Turnover
85,419
85,603
88,072
87,181
89,515
89,024
82,974
77,722
79,231
88,750
91,484
95,582
96,300
- -
Operating Margin (%)
5.89
5.43
6.85
8.1
7
5.66
6.4
1.76
7.37
8.07
10.24
9.13
7.17
- -
Depreciation Expense
3,407
3,902
3,388
3,496
3,639
3,915
4,072
3,955
3,736
3,718
3,330
3,204
4,677
- -
Net Income, GAAP
3,590
3,795
4,129
4,330
5,640
3,085
-8,933
-1,618
21,582
6,414
8,755
9,388
7,035
- -
Effective Tax Rate (%)
32.19
27.63
32.02
29.15
32.06
39.96
- -
- -
- -
18.33
26.44
26.08
31.28
- -
Profit Margin (%)
4.2
4.43
4.69
4.97
6.3
3.47
-10.77
-2.08
27.24
7.23
9.57
9.82
7.31
- -
Working Capital
29,014
28,040
28,918
29,390
31,002
29,353
16,324
514
34,569
39,202
35,404
44,570
46,793
- -
LT Debt
1,010
738
435
19,192
17,000
15,243
13,870
451
13,860
11,254
4,115
6,541
5,200
- -
Total Equity
67,253
76,082
74,406
53,916
60,109
60,786
46,789
46,674
66,539
71,371
76,643
79,200
83,379
- -
Return on Invested Capital (%)
4.47
3.96
4.63
5.7
4.83
3.46
- -
- -
- -
6.82
7.61
6.98
5.18
- -
Return on Capital (%)
5.13
4.92
5.13
5.53
7.09
4.08
- -
- -
- -
7.67
9.89
10.42
7.92
- -
Return on Common Equity (%)
5.66
5.34
5.53
6.81
9.98
5.14
-16.76
-3.5
38.31
9.3
11.83
12.05
8.66
- -

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
3,430
1,941
- -
LT Borrowings
5,232
5,200
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
30
29
29
Market Capitalization
86,052
83,827
88,840

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
63,721
66,227
- -
Cash, Cash Equivalents & STI
17,319
20,070
- -
Accounts Receivable, Net
21,073
21,384
- -
Inventories
22,300
22,061
- -
Total Current Liabilities
20,254
19,434
- -
Payables & Accruals
- -
- -
- -
ST Debt
3,430
1,941
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.76%
13.17%
5.28%
Free Cash Flow
67.19%
-9.65%
-73.5%
Net Income, GAAP
-196.71%
-297.1%
-25.06%
Sales/Revenue/Turnover
1.02%
4.45%
0.75%
Total Cash Common Dividend
9.9%
18.89%
16.79%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
95,582
2026
- -
- -
- -
- -
96,300
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
310.08
2026
- -
- -
- -
- -
238.18
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
91.69
2026
- -
- -
- -
- -
109.76
2027
- -
- -
- -
- -
- -

Company Description

CEO
Atsushi Mochizuki
Full Time Employees
1,887
Sector
Consumer non-durables
Industry
Food: specialty/candy
Address
1-6-1 Yotsuya Tokyo TY Japan 160-0004
IPO Date
Oct 2, 1961
Business
Riken Vitamin Co., Ltd. manufactures and sells food ingredients, food improving agents, health care products, consumer and commercial foods, chemical improving agents, and vitamins primarily in Japan with overseas operations. The company offers household food products including non-oil dressings such as Riken Non-Oil Aojiso and Indo Kareya-san no Nazo Dressing, seaweed products like Fueru Wakame-chan, Furikakeru Zakuzaku Wakame, and Wakame Soup, extracts and seasonings such as Sozairyoku Dashi, retort-packed foods, salad-related products, seafood and meat extracts, and cut wakame; commercial food products and processed food raw materials for school lunch programs, restaurants, convenience stores, and processed food manufacturers; food improving agents including emulsifiers for bread, cake, whipped topping, coffee cream, margarine, tofu, jam, ice cream, noodles, and mashed potatoes, processed oils, natural colorants, vitamin E, anti-staling agents, foaming agents, coagulation agents, anti-sticking agents, texture improvers, and antioxidants; health care products such as crocetin (Crovit), mekabu fucoidan, carotenoids, vitamins, pork extract, and microencapsulation services; and chemical improving agents for anti-fogging, plasticization, lubrication, anti-static, thickening, cleaning, mold release, dispersion, and antioxidants, plus glycerol, polyglycerol, sorbitan, propylene glycol, specialty esters, and animal feed additives. Riken Vitamin operates eight factories in Japan including Tokyo, Osaka, Soka, Chiba, Kyoto, and others, and three overseas production facilities, with sales subsidiaries and application centers in North America, Southeast Asia, South Asia, China, the Middle East, Oceania, Europe, Africa, Latin America, Taiwan, and South Korea; subsidiaries include Riken Food Co., Ltd., Riken Vitamin USA, Inc., Tianjin Rikevita Food Co., Ltd., Rikevita (Malaysia) Sdn. Bhd., Rikevita (Singapore) Pte Ltd., Rikevita Fine Chemical & Food Industry (Shanghai) Co., Ltd., Guymon Extracts Inc., Rikevita (India) Private Limited, and Rikevita Turkey Food Industry Limited Company. Founded in 1949 as Riken Vitamin Oil Co., Ltd. from the Vitamin A Department of Riken Eiyou Yakuhin Co., Ltd. and renamed Riken Vitamin Co., Ltd. in 1980, the company is headquartered in Shinjuku-ku, Tokyo, Japan, and listed on the Tokyo Stock Exchange First Section (4526). Recent developments include the opening of a food-improving agent Application Center at Riken Vitamin USA, Inc. in June 2024; investments to expand the improving-agent factory at Tianjin Rikevita Food (new factory start in April 2025) and production facilities at Guymon Extracts (start in summer 2026); dissolution of the capital and business alliance with Kikkoman Corporation in FY2023 with repurchase of shares; establishment of Rikevita (Thailand) Co., Ltd. and Rikevita Viet Nam Co., Ltd. in 2025; launch of hit products Furikakeru Zakuzaku Wakame (Nikkei Trendy 2023) and Indo Kareya-san no Nazo Dressing in 2023; construction of a vitamin-mix wing at Tokyo Factory (start 2025); reduction of cross-shareholdings targeting under 20% of net assets by March 2025; and initiatives for eco-packaging, food loss reduction, and seaweed aquaculture revitalization.